register

News & Trends - MedTech & Diagnostics

Saliva tests to replace nasal swabs for COVID-19 diagnosis

Health Industry Hub | May 25, 2020 |

MedTech News: Saliva could be humanity’s best friend in fighting the COVID-19 pandemic, University of Queensland researchers have found.

Dr Pingping Han, a postdoctoral research fellow in UQ’s School of Dentistry, said saliva can be used to diagnose the presence and transmission of COVID-19, and to monitor immunity to the virus.

“Ironically saliva is a leading way that disease is transmitted, via droplets on surfaces and in the air, but it can also be incredibly useful to us for diagnosing the virus and monitoring a person’s health,” Dr Han said.

“Saliva is easy to access, collecting samples is non-invasive, and the procedure to diagnose COVID-19 is low-cost.”

Dr Han said she wanted researchers, clinicians, policymakers and the public to understand saliva’s value in the coronavirus pandemic.

 “Saliva testing allows quick, accurate and non-invasive detection in symptomatic and asymptomatic patients, as well as determination of a patient’s immune status. It is ideal for effective, large-scale pandemic control measures to prevent COVID-19’s spread.”

Dr Han noted the United States’ Food and Drug Administration last week approved the first SARS-CoV-2 coronavirus test that will allow people to collect their own saliva at home and send to a lab for results.

She said her research team hoped their review would guide the development of environmental and therapeutic strategies to reduce transmission of the virus, and help minimise risks to health professionals and others.

“Further studies into microbial pathogens such as bacteria and viruses and immunological antibodies are urgently required, to help validate saliva for future routine specimen collections, in this and future pandemics,” Dr Han said.

The study included a review on the three clinical studies on salivary diagnostics available at the time, this study was prepared.

It outlines the potential mechanism saliva uses to transmit the virus, and how saliva is a readily accessible diagnostic tool for detecting the virus’s presence.

Professor Sašo Ivanovski from UQ’s School of Dentistry co-led the study, which is published in Diagnostics.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.